S5G4T-1

DRUG3 trials

Sponsors

Sol-Gel Technologies, Ltd.

Conditions

Papulopustular Rosacea

Phase 3

A Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

CompletedNCT03448939

Sol-Gel Technologies, Ltd.Papulopustular Rosacea

Start: 2018-06-18End: 2019-05-24Updated: 2021-12-14

A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea

CompletedNCT03564119

Sol-Gel Technologies, Ltd.Papulopustular Rosacea

Start: 2018-06-21End: 2019-06-10Updated: 2021-12-15

A Long-Term Safety Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

TerminatedNCT03564145

Sol-Gel Technologies, Ltd.Papulopustular Rosacea

Start: 2018-09-12End: 2019-11-13Updated: 2021-12-15